Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

Oxaliplatin-induced Portal Hypertension

NCT04524676
unknownphase_2

The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China

NCT04228393
completednot_applicable

Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)

NCT02488499
unknown

Individualized Treatment With Traditional Chinese Medicine for the Patients With Insomnia Disorder: a Cohort Study

NCT02402959

Clinical Trials (4)

Showing 4 of 4 trials
NCT04524676Not Applicable

Oxaliplatin-induced Portal Hypertension

Unknown
NCT04228393Phase 2

The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China

Unknown
NCT02488499Not Applicable

Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)

Completed
NCT02402959

Individualized Treatment With Traditional Chinese Medicine for the Patients With Insomnia Disorder: a Cohort Study

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4